Richard W. Dugan, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 6,500 shares at $9.85 ($64K) on 2022-05-31, disclosed to the SEC on 2022-06-02.
Seasonal sale ($64k) by Director — this insider has traded VNDA in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| VNDA | SELL | 2019-08-28 | $223K | — | Filing → |
| VNDA | SELL | 2015-03-10 | $51K | — | Filing → |